Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES)
Clinical trial NCT03126227 · COMPLETED
Trial details
- NCT number
- NCT03126227
- Sponsor
- Aimmune Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-08
- Primary completion
- 2018-08-31
- Enrollment
- 506
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.